A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer

  • Kei Saito
  • , Hiroyuki Isayama
  • , Yoshihiro Sakamoto
  • , Yousuke Nakai
  • , Kazunaga Ishigaki
  • , Mariko Tanaka
  • , Takeyuki Watadani
  • , Junichi Arita
  • , Naminatsu Takahara
  • , Suguru Mizuno
  • , Hirofumi Kogure
  • , Hideaki Ijichi
  • , Keisuke Tateishi
  • , Minoru Tada
  • , Kiyoshi Hasegawa
  • , Masashi Fukayama
  • , Norihiro Kokudo
  • , Kazuhiko Koike

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science